TCG Lifesciences (TCGLS), a leading research services and informatics company of New York based Chatterjee Group with operations in India, Europe, Japan and the United States, has launched its Australian operations to offer highly efficient and sought-after discovery research and development services. TCGLS has entered collaboration with Mantrax Ventures to represent it in Australia and enable Australian companies to attain cost-effective, accelerated development of their latent IP and product pipeline.

Mantrax Ventures is TCGLS' Australian business development partner. Mantrax facilitates alliances between India, Japan and Australia, particularly in high technology areas, through sourcing from contract research and manufacturing organizations, licensing of intellectual property and value-adding to 'orphan' technologies. The group also has strong connections to investors keen to review Australian assets.

Dr Kapil Talwar, director, Mantrax Ventures said, "TCGLS assists partner companies to expand and strengthen product pipelines. The in-house expertise, track-record and unique integrated research platform significantly lowers up-front and ongoing costs of research and development."

Swapan Bhattacharya, managing director, TCGLS, said, "Our talented scientists and state-o-the-art research facilities enable us to engage seamlessly with our partners to accelerate and enhance the drug development process securely under one roof.. We want to dedicate ourselves to helping unlock the vast potential of intellectual property assets which exist at Australian life science companies. Our flexible engagement models help in creating a win-win situation across stakeholders. A large benefit of our outsourcing model is that our partners are serviced by a dedicated project team and all intellectual property generated is owned by them."

TCGLS collaborates to service the multidisciplinary research, efforts of global pharmaceutical and biotechnology companies through its three units Chembiotek (discovery research), Clininvent (clinical research solutions) and Lab Vantage (enterprise informatics). It has trust based relationships with a majority of the global pharmaceutical companies.